Works by Shukla, Arti


Results: 52
    1
    2
    3
    4
    5

    Extracellular Signal-Regulated Kinase 5 and Cyclic AMP Response Element Binding Protein Are Novel Pathways Inhibited by Vandetanib (ZD6474) and Doxorubicin in Mesotheliomas.

    Published in:
    American Journal of Respiratory Cell & Molecular Biology, 2014, v. 51, n. 5, p. 595, doi. 10.1165/rcmb.2013-0373TR
    By:
    • Sayan, Mutlay;
    • Shukla, Arti;
    • MacPherson, Maximilian B.;
    • Macura, Sherrill L.;
    • Hillegass, Jedd M.;
    • Perkins, Timothy N.;
    • Thompson, Joyce K.;
    • Beuschel, Stacie L.;
    • Miller, Jill M.;
    • Mossman, Brooke T.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Assessing nanotoxicity in cells in vitro.

    Published in:
    WIREs: Nanomedicine & Nanobiotechnology, 2010, v. 2, n. 3, p. 219, doi. 10.1002/wnan.54
    By:
    • Hillegass, Jedd M.;
    • Shukla, Arti;
    • Lathrop, Sherrill A.;
    • MacPherson, Maximilian B.;
    • Fukagawa, Naomi K.;
    • Mossman, Brooke T.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Fusarium Wilt of Cucumber-A Review.

    Published in:
    International Journal of Economic Plants, 2021, v. 8, n. 4, p. 193, doi. 10.23910/2/2021.0423
    By:
    • Sharma, Deepika;
    • Shukla, Arti
    Publication type:
    Article
    28
    29
    30

    ERK2 is essential for the growth of human epithelioid malignant mesotheliomas.

    Published in:
    International Journal of Cancer, 2011, v. 129, n. 5, p. 1075, doi. 10.1002/ijc.25763
    By:
    • Shukla, Arti;
    • Hillegass, Jedd M.;
    • MacPherson, Maximilian B.;
    • Beuschel, Stacie L.;
    • Vacek, Pamela M.;
    • Butnor, Kelly J.;
    • Pass, Harvey I.;
    • Carbone, Michele;
    • Testa, Joseph R.;
    • Heintz, Nicholas H.;
    • Mossman, Brooke T.
    Publication type:
    Article
    31

    Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy.

    Published in:
    International Journal of Cancer, 2011, v. 129, n. 1, p. 233, doi. 10.1002/ijc.25666
    By:
    • Hillegass, Jedd M.;
    • Blumen, Steven R.;
    • Cheng, Kai;
    • MacPherson, Maximilian B.;
    • Alexeeva, Vlada;
    • Lathrop, Sherrill A.;
    • Beuschel, Stacie L.;
    • Steinbacher, Jeremy L.;
    • Butnor, Kelly J.;
    • Ramos-Niño, Maria E.;
    • Shukla, Arti;
    • James, Ted A.;
    • Weiss, Daniel J.;
    • Taatjes, Douglas J.;
    • Pass, Harvey I.;
    • Carbone, Michele;
    • Landry, Christopher C.;
    • Mossman, Brooke T.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.

    Published in:
    PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127310
    By:
    • Cunniff, Brian;
    • Newick, Kheng;
    • Nelson, Kimberly J.;
    • Wozniak, Alexandra N.;
    • Beuschel, Stacie;
    • Leavitt, Bruce;
    • Bhave, Anant;
    • Butnor, Kelly;
    • Koenig, Andreas;
    • Chouchani, Edward T.;
    • James, Andrew M.;
    • Haynes, Alexina C.;
    • Lowther, W. Todd;
    • Murphy, Michael P.;
    • Shukla, Arti;
    • Heintz, Nicholas H.
    Publication type:
    Article
    47
    48
    49
    50